Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors 1,2 . Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2-and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity 3, 4 . Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias 5-9 . Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCF Skp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll 2/2 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or DSET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll-CBP knock-in allele that mimics human t(11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.
Cell cycle checkpoints are implemented to safeguard the genome, avoiding the accumulation of genetic errors 1, 2 . Checkpoint loss results in genomic instability and contributes to the evolution of cancer. Among G1-, S-, G2-and M-phase checkpoints, genetic studies indicate the role of an intact S-phase checkpoint in maintaining genome integrity 3, 4 . Although the basic framework of the S-phase checkpoint in multicellular organisms has been outlined, the mechanistic details remain to be elucidated. Human chromosome-11 band-q23 translocations disrupting the MLL gene lead to poor prognostic leukaemias [5] [6] [7] [8] [9] . Here we assign MLL as a novel effector in the mammalian S-phase checkpoint network and identify checkpoint dysfunction as an underlying mechanism of MLL leukaemias. MLL is phosphorylated at serine 516 by ATR in response to genotoxic stress in the S phase, which disrupts its interaction with, and hence its degradation by, the SCF Skp2 E3 ligase, leading to its accumulation. Stabilized MLL protein accumulates on chromatin, methylates histone H3 lysine 4 at late replication origins and inhibits the loading of CDC45 to delay DNA replication. Cells deficient in MLL showed radioresistant DNA synthesis and chromatid-type genomic abnormalities, indicative of S-phase checkpoint dysfunction. Reconstitution of Mll 2/2 (Mll also known as Mll1) mouse embryonic fibroblasts with wild-type but not S516A or DSET mutant MLL rescues the S-phase checkpoint defects. Moreover, murine myeloid progenitor cells carrying an Mll-CBP knock-in allele that mimics human t (11;16) leukaemia show a severe radioresistant DNA synthesis phenotype. MLL fusions function as dominant negative mutants that abrogate the ATR-mediated phosphorylation/stabilization of wild-type MLL on damage to DNA, and thus compromise the S-phase checkpoint. Together, our results identify MLL as a key constituent of the mammalian DNA damage response pathway and show that deregulation of the S-phase checkpoint incurred by MLL translocations probably contributes to the pathogenesis of human MLL leukaemias.
Leukaemogenic MLL translocations fuse the common MLL aminoterminal 1,400 amino acids in frame with more than 60 partners 8 . The MLL gene encodes a 500-kD precursor, MLL 500 , which is processed by TASP1 10 to generate mature, heterodimerized MLL N320/C180 . MLL participates in embryogenesis, cell fate, cell cycle and stem cell function 7, [11] [12] [13] [14] , in part by methylating histone H3K4 through its carboxy-terminal SET domain 15 . Although the importance of HOX gene deregulation in the pathogenesis of MLL leukaemias has been extensively investigated [5] [6] [7] [8] , physiological MLL-fusion knock-in mouse models indicate that HOX gene aberrations alone are insufficient to initiate MLL leukaemias 7, 16 .
MLL participates in cell cycle control 12, [17] [18] [19] and has a biphasic expression with peaks at G1/S and G2/M transitions 12 . These unique two peaks are conferred by proteasome-mediated degradation: SCF Skp2 and APC Cdc20 degrade MLL at the S and M phases, respectively 12 . Why MLL needs to be degraded in the S and M phases is unclear. The observation that overexpression of MLL impedes S-phase progression 12 raises a testable hypothesis that MLL may accumulate in the S phase on DNA damage to delay DNA replication for repair. Indeed, tested DNA perturbation agents, including aphidocolin, hydroxyurea, ultraviolet light, etoposide and c-ionizing radiation, induced the MLL protein expression ( Fig. 1a and Supplementary Fig. 1a , b). The MLL protein was induced on DNA damage in the S phase, but not in the G1 or M phases, through a transcriptionindependent mechanism ( Fig. 1b and Supplementary Fig. 1c ).
The S-phase checkpoint senses DNA damage, activates ATM or ATR, inhibits the firing of late replication origins and enlists repair machineries. 'Chromatid-type' genomic errors, accrued during the S phase, include quadriradials, triradials and chromatid gaps and breaks 20 . Metaphase spread analysis demonstrated a higher incidence of chromatid-type errors in Mll 2/2 than in wild-type cells on mitomycin C treatment ( Fig. 1c ). Cells with compromised S-phase checkpoints show radioresistant DNA synthesis 3 (RDS). Knockdown of MLL in 293T cells or genetic deletion of Mll in mouse embryonic fibroblasts (MEFs) resulted in RDS ( Fig. 1d ), confirming a critical role for wild-type MLL in the mammalian S-phase checkpoint. To explore whether MLL fusions incur S-phase checkpoint defects, we generated myeloid precursor cells (MPCs) from Mll 1/ex7(stop)CBP mice that carry a knock-in inducible Mll ex7-CBP allele 21 (Supplementary Fig. 2 ). Mll 1/ex7(stop)CBP MPCs retained only one copy of wildtype Mll and consequently exhibited a partial RDS phenotype (Fig. 1e ). Remarkably, a severe RDS phenotype was observed in Mll 1/ex7-CBP MPCs (Fig. 1e ). These data suggest that Mll-CBP functions as a dominant negative mutant that actively compromises the S-phase checkpoint, contributing to the acquisition of additional chromosomal translocations observed in Mll 1/ex7-CBP leukaemias 21 . Furthermore, expression of MLL-AF4 (AF4 also known as AFF1) or MLL-AF9 (AF9 also known as MLLT3) in Jurkat T cells resulted in an RDS phenotype despite the presence of two wild-type MLL alleles ( Supplementary Fig. 3 ). Consistently, expression of MLL-ENL (ENL also known as MLLT1) in progenitor cells increased chromosomal abnormalities on etoposide treatment 22 .
MLL is normally degraded in the S phase by SCF Skp2 , which directly binds to the N-terminal 1,400 amino acids of MLL 12 . It is possible that signal transduction triggered by DNA damage disrupts the MLL-Skp2 interaction and thereby induces MLL, which was indeed observed ( Fig. 2a ). As the DNA damage response network relays signals mainly through phosphorylation, we examined whether inhibition of proximal kinases including ATM, ATR and DNA-PKcs prohibited the DNA-damage-induced MLL accumulation. LY294002 and wortmannin abolished the MLL accumulation on DNA damage (Fig. 2b ). To specify key kinase(s) required for such signalling, we used MEFs with deletion of ATM, ATR or DNA-PKcs 23,24 (PRKDC). Deficiency in ATR greatly reduced the accumulation of Mll on DNA damage ( Fig. 2c and Supplementary Fig. 4 ), identifying ATR as the principal kinase for the MLL induction.
As DNA damage signals disrupt the MLL-Skp2 interaction, ATR might directly or indirectly phosphorylate MLL and/or Skp2, leading to their dissociation. Bioinformatics analysis (http://scansite.mit. edu) identified a candidate ATM or ATR site at conserved serine 516 (LPISQSP) of MLL (Fig. 3a) . In contrast to the disrupted interaction between wild-type MLL and Skp2 on hydroxyurea treatment, a comparable interaction was detected between MLL(S516A) and Skp2 irrespective of DNA insults (Fig. 3b ), suggesting that Ser 516 phosphorylation dissociates MLL from Skp2. The Ser 516 of MLL became phosphorylated after hydroxyurea treatment (Fig. 3b ), correlating with diminished MLL-Skp2 interaction. To assess whether ATR can directly phosphorylate MLL, we performed in vitro kinase assays using affinity-purified ATR and recombinant MLL proteins.
As ATR needs to be fully activated by TOPBP1 or CLSPN 25 , purified ATR only weakly phosphorylated wild-type but not S516A MLL protein (Fig. 3c ). Once activated by TOPBP1, ATR effectively phosphorylated MLL, which detected by both anti-phospho-ATM/ ATR substrate and anti-phospho-MLL(S516) antibodies (Fig. 3c) .
To assess the functional significance of Ser 516 phosphorylation, Mll 2/2 MEFs reconstituted with wild-type or S516A human MLL ( Supplementary Fig. 5 ) were subjected to RDS and metaphase spread assays (Fig. 3d, e ). Unlike wild-type MLL, S516A MLL failed to fully rescue the RDS defects and chromatid-type errors of Mll 2/2 MEFs (Fig. 3d, e ). Although S516A MLL is defective in the S-phase checkpoint, its interaction with menin and WDR5 and targeting to the promoters of Hoxa9 and Meis1 remain intact as in wild-type MLL ( Supplementary Fig. 6 ).
To investigate the mechanism(s) by which MLL engages the S-phase checkpoint, we determined whether MLL deficiency affects the upstream signal transduction on DNA damage. Like wild-type MEFs, Mll 2/2 cells were competent in the formation of c-H2AX (c-H2AFX) foci ( Supplementary Fig. 7a ). The autophosphorylation of ATM, the Ser 139 phosphorylation of H2AX, the ATM-mediated activating phosphorylation of Chk2 (Chek2), and the ATR-mediated activating phosphorylation of Chk1 (Chek1) were not affected by the MLL deficiency ( Supplementary Fig. 7b, c) . Furthermore, the phosphorylation of SMC1A by ATM or ATR, the degradation of CDC25A signalled by Chk kinases and the Tyr 15 phosphorylation of CDK2 were also not altered in MLL-deficient cells ( Supplementary Fig. 7d ).
The key effector step at the initiation of DNA replication is the loading of CDC45 onto the pre-replication complex, which consists of the origin recognition complex and the MCM2-7 complex 26 . The chromatin association of CDC45 correlates well with DNA synthesis and thus marks the firing of replication origins 26 . Supporting the role of MLL in the S-phase checkpoint, an aberrant chromatin association of CDC45 was observed in MLL-deficient cells on DNA insults, whereas the chromatin association of MCM2 was not altered ( Fig. 4a and Supplementary Fig. 8 ). The S-phase checkpoint commenced at ATM or ATR activation ultimately inhibits CDC45 loading, in part through deactivating CDK2 and Dbf4-dependent kinase 3, 27, 28 , which was not affected by the MLL deficiency ( Supplementary Figs 7d and 9 ). Furthermore, the MLL-mediated inhibition of chromatin association of CDC45 was transcription independent ( Supplementary Fig. 10 ). Chromatin immunoprecipitation (ChIP) assays on the b-globin gene origin, a well-characterized late replication origin in 293T cells 29 , demonstrated that MLL accumulated and methylated H3K4 at the and then subjected to pull-down assays using streptavidin beads. The precipitated H3 peptides were visualized by Coomassie-blue staining, whereas co-precipitated CDC45 was detected by anti-CDC45 immunoblots. e, The indicated Jurkat cells were treated with 25 mM etoposide for 90 min, fractionated and then subjected to immunoblots using the indicated antibodies. MLL C180 denotes endogenous wild-type MLL. f, ChIP assays were performed using the indicated antibodies on Jurkat cells after etoposide treatment. Immunoprecipitated b-globin replication origin was amplified by PCR. g, 293T cells transfected with FLAG-MLL 6 FLAG-MLL-AF9 were treated with hydroxyurea for 90 min and then subjected to coimmunoprecipitation assays using the indicated antibodies. h, Model depicting how MLL and MLL fusions affect the S-phase checkpoint response. Pre-RC, pre-replication complex; pre-IC, pre-initiation complex.
b-globin gene origin on DNA damage, resulting in a decreased CDC45 occupancy (Fig. 4b) . These data suggest that the histone methyltransferase activity of MLL may be required for the execution of the S-phase checkpoint, which is corroborated by the inability of the DSET MLL mutant to fully correct the RDS defects and chromatid-type errors of Mll 2/2 MEFs (Fig. 3d, e ). In fact, histone H3 directly interacted with CDC45 and this interaction was greatly compromised when H3K4 was trimethylated ( Fig. 4c, d) . Data presented so far support a model in which stabilized MLL accumulates on chromatin to methylate H3K4 at late replication origins on S-phase checkpoint activation, which inhibits CDC45 loading and thereby delays DNA replication (Fig. 4h ). Although MLL probably methylates H3K4 at all late replication origins on DNA damage, genome-wide studies are required to conclude such a mechanism. We next investigated how MLL fusions function as dominant negative mutants in the S-phase checkpoint. Notably, all MLL fusions have lost their C-terminal SET domains ( Fig. 3a) and tested MLL fusions were resistant to the Skp2-mediated degradation due to impaired interaction 12 . Accordingly, MLL-AF4 and MLL-AF9 were not further stabilized on DNA damage despite the increased Ser 516 phosphorylation ( Supplementary Fig. 11 ). Chromatin association assays revealed an aberrant loading of CDC45 on DNA damage in Jurkat T cells that stably express MLL-AF4 or MLL-AF9 and in Mll 1/ex7-CBP MPCs ( Fig. 4e and Supplementary Fig. 12 ). Whereas MLL-AF4 and MLL-AF9 stably bound to chromatin, wild-type MLL (MLL C180 ) failed to accumulate on chromatin in the presence of MLL fusions (Fig. 4e) . Consequently, ChIP assays demonstrated a stable association of FLAG-MLL fusions, an ablated accumulation of MLL C180 , a failed induction of H3K4me3 and an aberrant loading of CDC45 on the late replication origin on genotoxic stress (Fig. 4f ). Together these data suggest that MLL fusions function as dominant negative mutants by preventing the stabilization of wild-type MLL on DNA insults. As the ATR-mediated phosphorylation and dissociation of wild-type MLL from Skp2 constitutes the initiating step of the MLL-mediated S-phase checkpoint response, MLL fusions might prevent the stabilization of wild-type MLL on DNA damage by abrogating the Ser 516 phosphorylation of wild-type MLL and thus preserving the interaction between wild-type MLL and Skp2. Because ATR associates with chromatin and becomes active on DNA insults 25 , the pre-occupancy of MLL fusions on chromatin would prohibit the access of wild-type MLL to the activated ATR. Co-expression of MLL-AF9 with wild-type MLL abrogated the Ser 516 phosphorylation of wild-type MLL but not MLL-AF9 on DNA insults, leading to a constitutive interaction/degradation of wild-type MLL by Skp2 (Fig. 4g ). The discovery of MLL in executing the S-phase checkpoint provides new mechanistic insights into not only normal cell biology but also the pathology underlying MLL leukaemias.
METHODS SUMMARY
Human embryonic kidney 293T cells, a cell line commonly used in assessing the S-phase checkpoint response 30 , was synchronized as previously described 12 . Both shRNA-mediated knockdown and quantitative PCR with reverse transcription of MLL have been described previously 12 , as have genetically defined MEFs including ATR f/1 , ATR f/2 , ATR f/1 ;ATM 2/2 , ATR f/2 ;ATM 2/2 , DNA-PKcs 2/2 and DNA-PKcs 1/1 MEFs 23,24 , and the Mll ex7(stop)CBP mice and the generation of MPCs 20, 21 . The modified Flp-In system is illustrated in Supplementary Fig. 5 .
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature.
